CD4 and cancer: For instance, during acute SARS-CoV-2 infection, a surge of IL-6 has been recently shown to awaken dormant tumor cells and drive cancer progression, a process facilitated by suppressive CD4+ T cells within the tumor microenvironment (Chia et al, 2025).